Myelodysplastic Syndrome Associated with Bone Marrow Fibrosis

References

• Rios A., Canizo M. C., Sanz M. A., Vallespi P., Sanz G., Torrabadella M., Gomis R., Ruiz C., San Miguel J. F. Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors. Br. J. Haematol. 1990; 75: 26–33
   PubMed Web of Science ®Google Scholar
• Thiele J., Quitman H., Wagner S., Fischer R. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens. J. Clin. Pathol. 1991; 44: 300–5
   PubMed Web of Science ®Google Scholar
• Kitagawa M., Kamiyama R., Takemura T., Kasuga T. Bone marrow analysis of the myelodysplastic syndromes histological and immunohistochemical features related to the evolution of overt leukemia. Virchows Archiv 1989; 57: 47–53
   Web of Science ®Google Scholar
• Yoshida Y., Oguma S., Uchino H., Maekawa T. Refractory myelodysplastic anemias with hypocellular bone marrow. J. Clin. Pathol 1989; 41: 763–7
   Web of Science ®Google Scholar
• Nand S., Godwin B. E. Hypoplastic myelodysplastic syndrome. Cancer 1988; 62: 958–64
   PubMed Web of Science ®Google Scholar
• Coiffier B., Adeleine P., Gentilhomme O., Felman P., Treille-Ritouet D., Bryon P. A. Myelodysplastic syndromes. A multiparametric study of prognostic factors in 336 patients. Cancer 1987; 60: 3029–32
   PubMed Web of Science ®Google Scholar
• Jacobs R. H., Cornbleet M. A., Vardiman J. W., Larson R. A., Le Beau M. M., Rowley J. D. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 1986; 67: 1765–72
   PubMed Web of Science ®Google Scholar
• Garcia S., Sanz M. A., Amigo V., Colomina P., Carrera M. D., Lorenzo J. I., Sanz G. F. Prognostic factors in chronic myelodysplastic syndromes: a multivariate analysis in 107 cases. Am. J. Hematol 1988; 27: 163–8
   PubMed Web of Science ®Google Scholar
• Sanz G. F., Sanz M. A., Vallespi T., Canizo M. C., Torrabadella M., Garcia S., Irriguible D., San Miguel J. F. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74: 395–408
   PubMed Web of Science ®Google Scholar
• Cassano E., Giordano M., Riccardi A., Cocci A., Cazzola M. Myelodysplastic syndromes: a multiparametric study of prognostic factors and a proposed scoring system. Haematologica 1990; 75: 141–5
   PubMedGoogle Scholar
• Hasselbach H. Idiopathic myelofibrosis: a clinical study of 80 patients. Am. J. Hematol. 1990; 34: 291–300
   PubMed Web of Science ®Google Scholar
• Yeung K. Y., Trowbridge A. A. Idiopathic acquired sideroblastic anemia terminating in acute myelofibrosis. Cancer 1977; 39: 359–65
   PubMed Web of Science ®Google Scholar
• Butler W. M., Taylor H. G., Viswanathan U. Idiopathic acquired sideroblastic anemia terminating in acute myelosclerosis. Cancer 1982; 49: 2497–9
   PubMed Web of Science ®Google Scholar
• Bearman R. M., Pangalis G. A., Rappaport H. Acute (“malignant”) myelosclerosis. Cancer 1979; 43: 279–93
   PubMed Web of Science ®Google Scholar
• Bain B. J., Catovsky D., O'Brien M., Prentice H. G., Lawlor E., Kumaran T. O., McCann S. R., Matutes E., Galton D. A. G. Megakaryoblastic leukemia presenting as acute myelofibrosis. A study of four cases with the platelet-peroxidase reaction. Blood 1981; 58: 206–13
   PubMed Web of Science ®Google Scholar
• Heilmeyer L. Disturbance in Heme Synthesis, C. C. Thomas, Springfield IL 1966; 132
   Google Scholar
• Lukowicz D. F., Myers T. J., Grasso J. A., Albala M. M. Sideroblastic anemia terminating in myelofibrosis. Am. J. Hematol. 1982; 13: 253–7
   PubMed Web of Science ®Google Scholar
• Sultan C., Sigaux F., Imbert M., Reyes F. Acute myelodysplasia with myelofibrosis: a report of eight cases. Br. J. Haematol 1981; 49: 11–16
   PubMed Web of Science ®Google Scholar
• Pagliuca A., Layton D. M., Manoharan A., Gordon S., Green P. J., Mufti G. J. Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases. Br. J. Haematol. 1989; 71: 499–504
   PubMed Web of Science ®Google Scholar
• Maschek H., Kaloutsi V., Georgii A. Myelosclerosis and myelofibrosis do reduce the life expectancy of MDS patients. 3rd Meeting of the European Association for Haemopathology., Wuerzburg, October, 1990; S4–13, Abstract
   Google Scholar
• Lambertenghi Deliliers G., Orazi A., Luksch R., Annaloro C., Soligo D. Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br. J. Haematol. 1991; 78: 161–6
   PubMed Web of Science ®Google Scholar
• Ohyashiki K., Sasao I., Ohyashiki J. H., Murakami T., Iwabuchi A., Tauchi T., Saito M., Nakazawa S., Serizaw H., Ebihara Y., Toyama K. Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis. Cancer 1990; 68: 178–83
   Web of Science ®Google Scholar
• Verhoef G. E. G., De Wolf-Peeters C., Ferrant A., Deprez S., Meeus P., Stul M., Zachee P., Cassiman J. J., Van den Berghe H., Boogaerts M. A. Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. Ann. Hematol. 1991; 63: 235–41
   PubMed Web of Science ®Google Scholar
• Shibata A., Takahashi M., Koike T., Narita M., Moriyama Y. Myelodysplastic syndrome with myelofibrosis: a report of seven cases. Blut 1988; 56: C22
   Google Scholar
• Takahashi M., Koike T., Nagayama R., Fujiwara M., Koyama S., Ohnishi M., Nakamori Y., Soga N., Aoki S., Tatewaki W., Wada K., Moriyama Y., Shibata A. Myelodysplastic syndrome with myelofibrosis: myelodysplastic syndrome as a major primary disorder for acute myelofibrosis. Clin. Lab. Haematol. 1991; 13: 17–23
   PubMedGoogle Scholar
• Wajima T., Olin E. Myelofibrosis in patients with myelodysplastic syndrome. Blood 1990; 76(Suppl 1)372a
   Google Scholar
• Verhoef G. E. G., De Wolf-Peeters C., Ferrant A., Boogaerts M. A. A case of myelodysplastic syndrome and myelofibrosis. Br. J. Haematol. 1990; 74: 373–5
   PubMed Web of Science ®Google Scholar
• Ohsaka A., Yawata Y., Enomoto Y., Takahashi A., Sato Y., Sakamoto S., Miura Y. Abnormal calcium transport of acanthocytes in acute myelodysplasia with myelofibrosis. Br. J. Haematol. 1989; 73: 568–70
   PubMed Web of Science ®Google Scholar
• Antin J. H., Weinberg D. S., Rosenthal D. S. Variable effect of recombinant human granulocyte-macrophage colony-stimulating factor on bone marrow fibrosis in patients with myelodysplasia. Exp. Hematol. 1990; 18: 266–70
   PubMed Web of Science ®Google Scholar
• Del Potro E., Martinez R., Krsnik I., Lopez Rubio M., Gonzalez Fernandez A., Villegas A. Myelofibrosis in primary myelodysplastic syndromes. Br. J. Haematol. 1989; 73: 281
   PubMed Web of Science ®Google Scholar
• Tricot G., De Wolf-Peeters C., Vlientinck R., Verwilghen R. L. Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS. Br. J. Haematol. 1984; 58: 217–25
   PubMed Web of Science ®Google Scholar
• Manoharan A., Horsley R., Pitney W. R. The reticulin content of bone marrow in acute leukaemia in adults. Br. J. Haematol. 1979; 43: 185–90
   PubMed Web of Science ®Google Scholar
• Reilly J. T., Dolan G. Proposed classification for the myelodysplasia/myelofibrosis syndromes. Br. J. Haematol. 1991; 79: 653
   PubMed Web of Science ®Google Scholar
• Appelbaum F. R., Storb R., Ramberg R. E., Shulman H. M., Buckner C. D., Clift R. A., Deeg H. J., Fefer A., Sanders J., Self S., Singer J., Stewart P., Sullivan K., Witherspoon R., Thomas E. D. Treatment of preleukemic syndromes with marrow transplantation. Blood 1987; 69: 92–6
   PubMed Web of Science ®Google Scholar
• Watts E. J., Major R. V., Green P. J., Mavor W. O. Hyperfibrotic myelodysplasia: a report of three cases showing haematological remission following treatment with prednisolone. Br. J. Haematol. 1991; 78: 120–2
   PubMed Web of Science ®Google Scholar
• Narayanan M. N., Benaim M. E., Geary C. G., Harrison C. J. Hyperfibrotic myelodysplasia. Br. J. Haematol. 1991; 79: 653–5
   PubMed Web of Science ®Google Scholar
• Orazi A., Cattoretti G., Soligo D., Luksch R., Lambertenghi-Deliliers G. Therapy-related myelodysplastic syndromes: prognostic implications of FAB classification, bone marrow histology and immunohistochemical assessment. Am. J. Clin. Pathol 1992, (manuscript in preparation)
   Google Scholar